James A. Underberg MS, MDClinical Assistant Professor of Medicine, NYU School of Medicine & The NYU Center for Prevention of Cardiovascular Disease; Director, Bellevue Hospital Lipid Clinic, New York, New York
Dr. Underberg is a Clinical Assistant Professor of Medicine at NYU School of Medicine and the NYU Center for Prevention of Cardiovascular Disease. He is the Director of the Bellevue Hospital Lipid Clinic.
Dr. Underberg is a Diplomate of the American Board of Clinical Lipidology, a Fellow of the National Lipid Association & Immediate Past-‐ President of the Northeast Lipid Association. He serves on the editorial board of the Journal of Clinical Lipidology and is a He is a board member of the National Lipid Association, the Foundation of the National Lipid Association and the American Board of Clinical Lipidology. Dr Underberg also serves on the scientific advisory board of the FH Foundation.
Dr. Underberg’s Clinical Interests focus on the clinical management of patients with lipids and lipoprotein disorders, hypertension management and cardiovascular disease prevention. He maintains an active clinical research program in these areas and has authored numerous articles and book chapters in the field of clinical lipidology.
He sees patients both at Bellevue Hospital and in a University based Private practice setting.
- Speaker Bureau: AstraZeneca, Amarin, Merck,Sanofi, Genzyme, Synageva , Amgen
- Consultant: Amgen, Aegerion, Sanofi, Esperion
- Research Grants: Kowa, Aegerion, Sanofi , Pfizer
- Board Positions: FH Foundation, National Lipid Association, ASH Foundation , Foundation NLA
- Editorial Board: Journal Clinical Lipidology